Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43100, Parma, Italy.
Cognitive and Motoric Center, Medicine and Geriatric-Rehabilitation Department of Parma, University-Hospital of Parma, 43126, Parma, Italy.
BMC Geriatr. 2020 Sep 9;20(1):337. doi: 10.1186/s12877-020-01746-x.
The association between amyloid deposition and cognitive, behavioral and physical performance in mild cognitive impairment (MCI) due to Alzheimer's disease (AD) has been poorly investigated, especially in older persons.
We studied the in vivo correlation between the amyloid deposition at Positron Emission Tomography (amyloid-PET) and the presence of memory loss, reduced executive function, neuropsychiatric symptoms and physical performance in older persons with MCI. Amyloid-PET was performed with 18F-flutemetamol and quantitatively analyzed.
We evaluated 48 subjects, 21 men and 27 women. We performed in each patient a comprehensive geriatric assessment (CGA) including Mini Mental State Examination (MMSE), Clock Drawing Test (CDT), Activity Daily Living (ADL), Instrumental Activity of Daily Living (IADL), Neuropsychiatric inventory (NPI) questionnaire, 15 Geriatric Depression Scale (GDS), Short Physical Performance Battery (SPPB) and Hand Grip strength. Then, each patient underwent amyloid-PET. Mean age of the enrolled subjects was 74.6 ± 7.8 years. All of these subjects showed preserved cognitive function at MMSE > 24, while 29 of 48 subjects (61.0%) had altered CDT. Mean NPI score was 6.9 ± 5.9. The mean value of SPPB score was 9.0 ± 2.6, while the average muscle strength of the upper extremities measured by hand grip was 25.6 ± 7.7 Kg. CT/MRI images showed cortical atrophic changes in 26 of the 48 examined subjects (54.0%), while cerebrovascular modifications were present in 31 subjects (64.5%). Pathological burden of amyloid deposits was detected in 25 of 48 (52.0%) patients with a mean value of global z-score of 2.8 (subjects defined as MCI due to AD). After stratifying subjects in subclasses of clinical alterations, more probability of pathological amyloid deposition was found in subjects with impaired CDT and higher NPI score (O.R. = 3.45 [1.01-11.2], p = 0.04), with both impaired CDT and low physical performance (O.R. = 5.80 [1.04-32.2], p = 0.04), with altered CDT and high NPI score (O.R. = 7.98 [1.38-46.0], p = 0.02), and finally in those subjects with altered CDT, high NPI and low physical performance (O.R. = 5.80 [1.05-32.2], p = 0.04).
Our findings support the recent hypothesis that amyloid deposition could be associated with multiple cerebral dysfunction, mainly affecting executive, behavioral and motor abilities.
在阿尔茨海默病(AD)导致的轻度认知障碍(MCI)患者中,淀粉样蛋白沉积与认知、行为和身体表现之间的关联研究甚少,尤其是在老年人中。
我们研究了正电子发射断层扫描(amyloid-PET)中淀粉样蛋白沉积与记忆力丧失、执行功能下降、神经精神症状和老年人 MCI 患者身体表现之间的体内相关性。使用 18F-氟脱氧葡萄糖(18F-flutemetamol)进行淀粉样蛋白-PET 并进行定量分析。
我们评估了 48 名受试者,21 名男性和 27 名女性。对每位患者进行了全面的老年评估(CGA),包括简易精神状态检查(MMSE)、画钟试验(CDT)、日常生活活动(ADL)、工具性日常生活活动(IADL)、神经精神问卷(NPI)、15 项老年抑郁量表(GDS)、简易体能状况量表(SPPB)和手握力测试。然后,每位患者均接受了淀粉样蛋白-PET 检查。入组患者的平均年龄为 74.6±7.8 岁。所有这些患者的 MMSE 评分均>24,表明认知功能正常,而 48 名患者中有 29 名(61.0%)的 CDT 异常。平均 NPI 得分为 6.9±5.9。SPPB 评分的平均值为 9.0±2.6,而上肢肌肉力量(握力)的平均测量值为 25.6±7.7 Kg。48 名检查患者中有 26 名(54.0%)的 CT/MRI 图像显示皮质萎缩改变,31 名(64.5%)患者存在脑血管改变。在 48 名患者中有 25 名(52.0%)发现了淀粉样蛋白沉积的病理性负担,其总 Z 评分的平均值为 2.8(被定义为 AD 导致的 MCI 的患者)。在对具有不同临床改变的患者进行分层后,发现 CDT 异常和 NPI 评分较高(O.R. = 3.45 [1.01-11.2],p = 0.04)、CDT 异常和身体机能较差(O.R. = 5.80 [1.04-32.2],p = 0.04)、CDT 异常和 NPI 评分较高(O.R. = 7.98 [1.38-46.0],p = 0.02)以及 CDT 异常、NPI 评分较高和身体机能较差(O.R. = 5.80 [1.05-32.2],p = 0.04)的患者发生病理性淀粉样蛋白沉积的可能性更高。
我们的研究结果支持了最近的假说,即淀粉样蛋白沉积可能与多种大脑功能障碍有关,主要影响执行、行为和运动能力。